Skip to main content
Google Tag Manager
P&T COMMUNITY
Search form
Search
News
Approvals, Launches, & New Indications
Pipeline Plus
Research News
Industry Trends
Safety Issues
Agency Actions
Health Care Reform
Guidelines
Clinical Trials
P&T
Current issue
Past issues
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Reports
Health Care & Law
Drug Forecast
More
Meeting Highlights
Medication Errors
Prescription: Washington
About
News
P&T Journal
You are here
Home
News by month %2 2015
News by month August 2015
PTCommunity News August 2015
CMS Advisors Recommend Hospital Payment for Advance Care Planning
FDA Approves New Indication for Seizure Therapy Eslicarbazepine (Aptiom)
Finerenone Cuts Deaths in Mid-Stage Trial
FDA Warns That DPP-4 Inhibitors for Type-2 Diabetes May Cause Severe Joint Pain
New 'Tissue Velcro' Could Help Repair Damaged Hearts
Medicare Pay Won’t Be Tailored to Providers
New York Hospital Begins Posting Online Patient Reviews of Physicians
FDA Approves Evolocumab (Repatha) to Treat Certain Patients With High Cholesterol
Empagliflozin/Metformin Combo Tablet Wins FDA Nod for Adults With Type-2 Diabetes
Scientists Develop Nasal Spray for Mental Illness
Positive Results Reported for Daratumumab in Multiple Myeloma Patients
Study: Use of Observation Stays Drives Up Costs for One in Four Medicare Patients
Medicare ACOs Saved $411M in 2014, But Few Earned Bonuses
FDA Lays Out Naming Rules for Lower-Cost Biotech Drugs
Electrical Nerve-Stimulation Device Prevents Migraine
Will FDA Finally Stop Impinging on Free Speech?
‘Cowboy Doctors’ and Health Care Spending
Latest Trend: Hospitals Build Bigger Rooms for Bigger Patients
FDA Accepts Application for Muscular Dystrophy Drug Eteplirsen
Oral Diabetes Treatment Semaglutide Enters Phase III Trial
An ICD-10 Checklist
Physicians Top List of Highest-Paying Jobs
FDA Expands Use of Eltrombopag (Promacta) in Young Children With Rare Blood Disorder
NIH Study Shows No Benefit of Omega-3 or Other Nutritional Supplements for Cognitive Decline
FDA Accepts Application for Afatinib (Gilotrif) for Treatment of Advanced Lung Cancer
Tests Used to Measure Internal Bleeding May Not Be Reliable, Study Finds
Radiation Costs, Individual Cancers Poorly Correlated
New Tool Compares Costs and Benefits of Cancer Treatments
Patient Navigators Linked to Shorter Hospital Stays
Market Report: Hyperphosphatemia Drug Auryxia Is Slow to Catch On
Three Steps for Improving Patient Satisfaction
Proposed Sepsis-Reporting Rules Could Lead to Overtreatment
FDA Accepts Botox (OnabotulinumtoxinA) Resubmission for Treatment of Lower-Limb Spasticity in Adults
Positive Results Reported for Meningococcal Vaccine Trumenba
Scientists Use Tiny Gold Rods to Relieve Intractable Pain
Five Factors That Indicate Patients May Be at Risk for Unplanned Readmissions
Another Scope-Related ‘Superbug’ Found at California Hospital
FDA: ‘Low T’ Therapy Has Yet to Be Proven
Report: Endometrial Cancer on Rise in U.S.
Empagliflozin (Jardiance) Reduces Cardiovascular Risk in Diabetes Patients
FDA Okays First Treatment for Sexual Desire Disorder
Positive Results Reported for Investigational Drug ITCA 650 in Diabetes Patients
Task Force Issues Draft Recommendation Statement for COPD Screening
Experts Warn of ‘Too-Big-to-Fail’ Hospital Mergers
Competition Forces Seattle Provider to Cut Outpatient Prices
Report: Only 10% of Heart Failure Patients Are Referred for Cardiac Rehab
Cost of Diabetes Drugs Often Overlooked –– But Shouldn’t Be
FDA Issues Warning to Scope Makers Over Spread of ‘Superbugs’
Brentuximab Vedotin (Adcetris) Wins Approval for Treatment of Hodgkin Lymphoma Patients
FDA Agrees to Review Pembrolizumab (Keytruda) for First-Line Treatment of Advanced Melanoma
CMS Delays Enforcement of Two-Midnight Rule
For Hospitals, Sleep and Patient Satisfaction May Go Hand in Hand
FDA Approves Use of OxyContin in Children Aged 11 to 16 Years
Atezolizumab Shrinks Lung Tumors in Pivotal Trial
Molecular Breast Imaging Increases Accurate Cancer Diagnoses, Mayo Clinic Finds
New Tool to Prevent Patient Falls Could Help Hospitals Save $1M in Costs
Market Report: Oral Treatments Take Center Stage as Neurologists Try to Stop MS Progression Sooner
Bevacizumab (Avastin) Eye Injections Not Linked to Higher Risk of Blindness
Scientists Make Opioids From Bioengineered Yeast Instead of Poppies
More Physicians Reporting Dissatisfaction With EHR Systems
Push to Vaccinate Health Workers Is On
JAMA Study: Performance Measures Neglect Health Care Overuse
Dasatinib (Sprycel) Gets Label Update
FDA Delays Review of Melanoma Drug Nivolumab (Opdivo)
FDA Accepts New Drug Application for Deutetrabenazine for Treatment of Huntington Disease
Notifying Patients of Their Observation Status Is Now Law
AbbVie to Seek Approval for Potential Blockbuster Leukemia Drug
High-Risk Medical Devices Backed by Few Studies, Authors Find
Elderly, Ambulatory Surgery Patients More Likely to Be Readmitted
NIH Report: Pain in the U.S.
Partnerships With ‘Harm Reduction Centers’ May Cut Hospital Readmissions
FDA Can’t Block ‘Truthful’ Marketing of Drug for Unapproved Uses, Judge Rules
Zubsolv (Buprenorphine/Naloxone) Wins FDA Nod for Induction of Maintenance Therapy in Opioid-Dependent Patients
Positive Results Reported for Respiratory Vaccine
FDA Accepts Supplemental NDA for Vortioxetine (Brintellix) for Patients With Major Depressive Disorder
CVS Health Urges Reconsideration of Cholesterol Management Guidelines
Study of 83,000 Vets Finds Cardiovascular Benefits to Testosterone Replacement
Drug Candidate Kills Cancer Cells Through Overstimulation
FDA Approves Keveyis for Primary Hyperkalemic and Hypokalemic Periodic Paralysis
Extension Study Supports Long-Term Safety and Efficacy of Eloctate
Prescription Medications Common in Pregnancy
Biomarker Could Predict Responses to Breast and Prostate Cancer Treatment
Scientists Adopt New Strategy to Find Huntington’s Disease Therapies
Brain's Ability to Clear Key Alzheimer's Protein Drops Sharply With Age
Web-Based Toolkit Aids Patient–Provider Communication
Prostate Cancer Survival Improves With Earlier Use of Docetaxel
Medicare Rule May Needlessly Extend Some Hospital Stays
New Diagnostic Guidelines for Myeloma
Ovarian Cancer Survival Is Higher Than Widely Believed
Pfizer and Synthon Join for Potential Generic Treatment of Multiple Sclerosis
CDC Modeling Predicts Growth of Drug-Resistant Infections
New Cancer Cocktails Expected to Test Price Ceilings
FDA Warning: Rare Cases of Brain Infection Reported With Fingolimod (Gilenya)
Hospitals Focus on Seniors to Prevent Readmissions
FDA Offers Guidance on Duodenoscope Cleaning
Oncologists Debate High Cost of Cancer Drugs
Half of U.S. Hospitals Again Fail to Escape Medicare’s Readmission Penalties
Medical Scopes and ‘Superbugs’: Infection Risk Greater Than Previously Thought
FDA Says ‘Yes’ to Levetiracetam (Spritam) for Epilepsy-Related Seizures
Naldemedine Shows Promise in Treatment of Opioid-Induced Constipation
Citing Hacking Risk, FDA Says Facilities Shouldn’t Use Symbiq Infusion Pump
Most States Fail on Price Transparency Laws
Rural Hospitals Call for Relief From Federal Regulations
FDA Approves Azelaic Acid Foam (Finacea) for Topical Treatment of Rosacea
Carcinoid Syndrome Treatment Telotristat Meets Primary Objective in Phase III Trial
FDA, Lilly Issue Warnings About Duloxetine
Orally-Disintegrating Clonazepam Tablets Approved by FDA
FDA Accepts NDA for Preos, Treatment for Osteoporosis in Postmenopausal Women
